Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Earth Science Tech, Inc. (ETST : OTC)
 
 • Company Description   
Earth Science Tech, Inc. is a biotechnology company. It is focused on delivering nutraceuticals, bioceuticals and dietary supplements to health, wellness, sports and alternative medicine. The Company's products include cannabidiol as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products. Earth Science Tech, Inc. is headquartered in Boca Raton, Florida.

Number of Employees: 76

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.21 Daily Weekly Monthly
20 Day Moving Average: 125,224 shares
Shares Outstanding: 294.30 (millions)
Market Capitalization: $61.80 (millions)
Beta: 1.85
52 Week High: $0.25
52 Week Low: $0.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 40.00% 34.74%
12 Week 34.62% 10.77%
Year To Date 68.00% 57.63%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
8950 SW 74TH CT SUITE 1401
-
MIAMI,FL 33156
USA		 ph: 305-724-5684
fax: -		 ir@earthsciencetech.com http://www.earthsciencetech.com
 
 • General Corporate Information   
Officers
Giorgio R. Saumat - Chief Executive Officer; Chairman and Director
Mario G. Tabraue - Chief Operating Officer and Director
Ernesto Flores - Chief Financial Officer and Director
Victoria Losada - Secretary and Director
Jeff P.H. Cazeau - Independent Director

Peer Information
Earth Science Tech, Inc. (CORR.)
Earth Science Tech, Inc. (RSPI)
Earth Science Tech, Inc. (CGXP)
Earth Science Tech, Inc. (BGEN)
Earth Science Tech, Inc. (GTBP)
Earth Science Tech, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 270311103
SIC: 2834
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 294.30
Most Recent Split Date: (:1)
Beta: 1.85
Market Capitalization: $61.80 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.02 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 10.50
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 16.05
Price/Cash Flow: 18.15
Price / Sales: 1.87
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 44.23%
vs. Previous Quarter: 18.01%
ROE
06/30/25 - -
03/31/25 - 96.42
12/31/24 - 75.93
ROA
06/30/25 - -
03/31/25 - 57.58
12/31/24 - 46.52
Current Ratio
06/30/25 - -
03/31/25 - 0.99
12/31/24 - 0.87
Quick Ratio
06/30/25 - -
03/31/25 - 0.83
12/31/24 - 0.81
Operating Margin
06/30/25 - -
03/31/25 - 9.82
12/31/24 - 7.41
Net Margin
06/30/25 - -
03/31/25 - 9.82
12/31/24 - 7.41
Pre-Tax Margin
06/30/25 - -
03/31/25 - 10.18
12/31/24 - 7.55
Book Value
06/30/25 - -
03/31/25 - 0.01
12/31/24 - 0.01
Inventory Turnover
06/30/25 - -
03/31/25 - 26.87
12/31/24 - 30.49
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.01
12/31/24 - 0.01
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.81
12/31/24 - 1.29
 

Powered by Zacks Investment Research ©